PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10592302-3	1999	Intraperitoneal administration of the ganglion blocker hexamethonium (20 mg/kg) or the beta-adrenergic antagonist propranolol (5 mg/kg) suppressed the CGRP-induced increases in VO(2), HR, T(co), and T(IBAT).	Hexamethonium	55-68	calcitonin-related polypeptide alpha	Rattus norvegicus	151-155	
15680490-9	2005	Ganglion blockade with hexamethonium did not influence CGRP release by RPC but abolished CGRP mediated myocardial PKCepsilon activation.	Hexamethonium	23-36	calcitonin-related polypeptide alpha	Rattus norvegicus	89-93	
8366251-8	1993	The increased responses after hexamethonium administration were augmented probably because of the enhanced release of other neuropeptides like SP and CGRP especially at 10 Hz and 20 Hz stimulation.	Hexamethonium	30-43	calcitonin-related polypeptide alpha	Rattus norvegicus	150-154	
3259432-8	1988	The tachycardia response to central CGRP was attenuated by pretreatment with propranolol or hexamethonium, indicating that the heart rate response was mediated, in part, through increases in cardiac sympathetic tone.	Hexamethonium	92-105	calcitonin-related polypeptide alpha	Rattus norvegicus	36-40	
1981173-5	1990	The cardioacceleration elicited by intrathecal CGRP was attenuated by intrathecal lidocaine administration and by combined bilateral vagotomy/hexamethonium treatment, but not by either treatment alone.	Hexamethonium	142-155	calcitonin-related polypeptide alpha	Rattus norvegicus	47-51